Skip to main content

Table 1 Quantitative implementation measures of implementation fidelity and reach

From: Exploring the effect of implementation and context on a stepped-wedge randomised controlled trial of a vital sign triage device in routine maternity care in low-resource settings

 

Implementation

Reach

Adoption

Site

Staff trained in roll-out period

Proportion of women with BP measurement pre-interventionψ

Proportion of women with BP measurement post-interventionψ

Unadjusted comparison

Facilities with working BP pre-intervention

Facilities with working BP post-intervention

Clinical areas using solely VSA at 6 months

Clinical areas using VSA with other devices at 6 months

Clinical areas using solely VSA at 12 months

Clinical areas using VSA with other devices at 12 months

 

N (%)

N (%)

N (%)

OR

(95% CI)

% (devices, HCP)

% (devices, HCP)

%

%

%

%

Addis Ababa

192 (36.9%)

*

*

*

100%

(1:3)

100%

(1:2)

33.3%

66.7%

Ï…

Ï…

Cap Haitien

189 (73.5%)

*

*

*

100%

(1:3)

100%

(1:3)

76.2%

23.8%

Ï…

Ï…

Freetown

243 (57.9%)

2199 (87.7%)

3335 (100%)

1.14

(1.12–1.16)

84·6% (1:13)

100%

(1:4)

73.1%

26.9%

96.2%

0.0%

Gokak

297 (87.1%)

*

*

*

97·5%

(1:1)

100% (1:0.7)

72.3%

27.7%

Ï…

Ï…

Harare

405 (69.9%)

*

*

*

92%

(1:12)

100%

(1:5)

Ï…

Ï…

Ï…

Ï…

Kampala

188 (16.5%)

*

*

*

92.3% (1:19)

100%

(1:4)

33.8%

47.9%

34.2%

47.9%

Lusaka

265 (33.9%)

*

*

*

100%

(1:10)

100%

(1:5)

75.9%

24.1%

Ï…

Ï…

Mbale

314 (59.2%)

4640 (42.6%)

11,300 (96.2%)

2.26

(2.21–2.31)

92%

(1:5)

100%

(1:2)

87.3%

9.9%

Ï…

Ï…

Ndola

349 (86.6%)

5673 (98.2%)

5782 (100%)

1.02

(1.0–1.2)

93.5%

(1:7)

100%

(1:2)

90.2%

9.8%

90.2%

9.8%

Zomba

305 (89.2%)

11,860 (88.4%)

10,783 (94.1%)

1.06

(1.06–1.07)

100%

(1:17)

100%

(1:2)

Ï…

Ï…

Ï…

Ï…

Total/Mean

2747 (61.1%)

6093 (79.2%)

7800 (97.6%)

1.30

(1.29–1.31)

95%

(1:9)

100%

(1:3)

73.1%

23.3%

73.5%

20.0%

  1. *Data not recorded; BP blood pressure, VSA Vital Signs Alert
  2. Ï…Data not available due to stepped wedge trial design (time point exceeded trial duration)
  3. ψRecorded for a 1-month period immediately prior to implementation, and a 1-month period 3 months after implementation